Perindopril belongs to a group of medicines ... have diabetes-related kidney problems sacubitril (available as fixed dose combination with another medicine valsartan), used to treat long-term ...

Forty-nine patients entered the run-in phase of the study and 47 patients met the entry requirements after 4 weeks of taking placebo and were randomised to the study ...

Patients with ejection fraction <40% were excluded. Patients were randomized to receive perindopril 2 mg daily or placebo. The primary outcome, the composite of all-cause mortality or unplanned ...